Thermo Fisher Scientific
TMO
1,162 hedge funds and large institutions have $66.3B invested in Thermo Fisher Scientific in 2017 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 418 increasing their positions, 477 reducing their positions, and 56 closing their positions.
23% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 56
12% more capital invested
Capital invested by funds: $59B → $66.3B (+$7.29B)
9% more funds holding in top 10
Funds holding in top 10: 90 → 98 (+8)
1.09% more ownership
Funds ownership: 86.53% → 87.62% (+1.1%)
0% more funds holding
Funds holding: 1,159 → 1,162 (+3)
12% less repeat investments, than reductions
Existing positions increased: 418 | Existing positions reduced: 477
31% less call options, than puts
Call options by funds: $167M | Put options by funds: $240M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$465M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$414M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$203M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$203M |
| 5 |
VAM
Veritas Asset Management
London,
United Kingdom
|
+$194M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$270M |
| 2 |
Renaissance Technologies
New York
|
-$133M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$104M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$81.4M |
| 5 |
Janus Henderson Group
London,
|
-$63.1M |
TMO Hedge Fund Activity: Q3 2017 in Review
1,162 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2017, worth a combined $66.3B — up 12% from $59B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new TMO positions and 56 closed out — a net gain of 13 holders — while 418 added to existing stakes and 477 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $465M. The largest seller was Massachusetts Financial Services, cutting an estimated $270M.
- 1,162 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2017, up from 1,159 in Q2 2017.
- Funds reported $66.3B of Thermo Fisher Scientific stock for Q3 2017, up 12% quarter-over-quarter.
- 69 funds opened new Thermo Fisher Scientific positions in Q3 2017 and 56 closed out, a net change of +13 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2017 was Fidelity Investments, an estimated $465M added.
- The largest Thermo Fisher Scientific seller in Q3 2017 was Massachusetts Financial Services, an estimated $270M sold.
Based on aggregated 13F filings for Q3 2017.